相关实验视频
Updated: May 16, 2025
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
胆二醇对非糖尿病慢性病的免疫和血管功能的影响
Kajal Kamboj1, Aruna Pariki2, Manphool Singhal2
1Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Frontiers in immunology
|May 9, 2025
概括
维生素D补充剂改善了慢性病 (CKD) 患者的免疫和血管功能. 胆甲醇治疗将免疫平衡转移到TH2,减少炎症,并增强血管功能.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
背景情况:
- 慢性病 (CKD) 患者中,维生素D缺乏是常见的.
- 它可能通过影响免疫和内皮功能,导致心血管疾病 (CVD).
研究的目的:
- 研究维生素D补充剂对免疫和血管功能的影响.
- 专注于非糖尿病患者,患有3-4期CKD和维生素D缺乏症.
主要方法:
- 这是一项单臂研究,对62名非糖尿病CKD患者进行了单臂研究 (eGFR为15-60毫升/分钟/1.73米2).
- 在基线和8周内服用了30万IU口服胆醇.
- 在基线和16周评估免疫,血管,内皮,炎症和生化参数.
主要成果:
- 胆醇增加了TH2细胞,减少了TH1细胞,表明免疫表型的转变.
- 观察到维生素D响应基因 (cathelicidin,IL-10,VDR,CYP27B1) 的mRNA表达增加.
- 减少了促炎性细胞因子 (IFN-γ,TNF-α,IL-23,IL-6) 和增加了抗炎性细胞因子 (IL-4,IL-10,IL-13).
- 流媒体扩张 (FMD) 从8.2%提高到14.1% (p<0.001).
结论:
- 胆醇补充剂对CKD患者的免疫功能产生积极影响.
- 它促进了TH2主导的免疫反应,并减少了炎症.
- 补充剂还可以增强血管功能,这表明它在缓解CKD中心血管疾病风险方面发挥了作用.
相关概念视频
01:25Role of Vitamins in Maintaining Bone Health
3.1K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.1K
01:11Renal Failure: Dose Adjustments
45
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
45
01:17Factors Affecting Renal Clearance: Renal Impairment
36
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
36
01:29Renal Regulation of Acid-Base Balance
192
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
192
01:06Renal Drug Clearance: Overview
87
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
87
01:29Chronic Pancreatitis II: Collaborative Care
50
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
50